GE HealthCare to Acquire Intelerad for $2.3B, Advancing a Cloud-First Imaging Strategy and Expanding Its Reach Across Ambulatory and Hospital Markets
GE HealthCare has signed an agreement to acquire Intelerad for $2.3 billion in cash, a move that significantly accelerates the company’s cloud-first transformation and strengthens its position across enterprise imaging in both hospital and rapidly growing outpatient care settings. The deal, announced November 20, is one of GE HealthCare’s most consequential digital-health acquisitions to date and reflects escalating industry demand for unified, AI-enabled imaging platforms that can operate reliably across the full continuum of care.
Intelerad, a longtime imaging software leader with a large footprint in ambulatory networks, teleradiology and outpatient radiology groups, will bring a suite of cloud-native PACS systems, AI orchestration technologies, diagnostic viewers, image exchange capabilities and workflow-management tools into GE HealthCare’s portfolio. The integration positions the combined business to offer an end-to-end enterprise imaging ecosystem that spans academic medical centers, community hospitals, ambulatory surgery centers and specialty imaging clinics.
GE HealthCare President and CEO Peter Arduini said the deal reflects an industry shift toward imaging environments that can seamlessly manage rising exam volumes, staffing pressures and the complexity of multimodality workflows. As providers face increasing demand for rapid, precise, and coordinated interpretation, Arduini said customers are looking for “cloud-enabled and intelligent solutions” that unify a historically fragmented imaging ecosystem. The acquisition, he added, strengthens GE HealthCare’s ability to deliver precision care at scale by pairing its AI and medical device portfolio with Intelerad’s advanced software infrastructure.
Intelerad’s outpatient leadership was a defining factor in the deal. The company maintains strong market penetration among ambulatory imaging centers, radiology groups and teleradiology companies segments that have been expanding at a faster clip than hospital-based imaging. GE HealthCare, by contrast, has long dominated enterprise imaging inside hospitals. Combining those footprints allows the company to market a single cloud-first platform across diverse care environments while expanding its addressable market by more than $2 billion globally. Outpatient enterprise imaging, according to GE HealthCare, is projected to grow at a double-digit compound annual rate as procedures shift to lower-cost sites and as providers look for interoperable platforms that reduce complexity.
Roland Rott, President and CEO of GE HealthCare’s Imaging segment, called Intelerad an “outstanding strategic fit,” emphasizing that the deal pairs GE’s scaled AI capabilities with Intelerad’s enterprise cloud expertise. He framed the combination as a way to simplify complex imaging workflows, remove operational friction and accelerate the adoption of next-generation digital tools across radiology and cardiology departments.
Intelerad CEO Jordan Bazinsky said joining GE HealthCare gives the company global reach and deeper access to hospital decision makers, both of which are critical for scaling cloud-based imaging software. Bazinsky said the combined organization will be able to deliver more integrated AI-enabled solutions that help customers manage growing complexity while improving care delivery.
Financially, the deal is expected to have an immediate impact on GE HealthCare’s top-line growth and adjusted EBIT margin once closed. Intelerad generates approximately $270 million in revenue, with roughly 90% recurring, and maintains an EBITDA margin above 30%, according to GE HealthCare. The company grew in the low double digits annually prior to the deal and is expected to accelerate further under GE’s commercial infrastructure. GE HealthCare projects a high-single-digit return on invested capital by year five, although the transaction will be slightly dilutive to adjusted EPS in the near term due to financing costs. Cost efficiencies are expected to offset this effect as the organizations integrate.
The transaction is expected to close in the first half of 2026, pending regulatory review and customary closing conditions. GE HealthCare intends to finance the acquisition using cash on hand supplemented by debt. Evercore is serving as GE HealthCare’s exclusive financial advisor, with Sidley Austin acting as deal counsel. UBS Investment Bank is the advisor to Intelerad, and Skadden is serving as legal counsel.
Related news
Scilex Secures Exclusive Global License for Tokenizing Biotech Assets Through Datavault AI Platform
Intelerad, founded in Montreal in 1999, has grown into one of the largest independent enterprise imaging vendors, serving more than 1,500 healthcare organizations worldwide. Its majority shareholder, Hg Capital, and TA Associates will fully exit their positions after the transaction closes. The acquisition adds meaningful scale to GE HealthCare’s enterprise imaging software business at a time when cloud-native deployment, AI orchestration and integrated workflow management have become central to radiology modernization.
As imaging volumes climb and providers look for more efficient, interoperable systems to manage clinical and operational pressures, GE HealthCare is positioning itself as a full-stack imaging solutions provider. The addition of Intelerad its cloud architecture, SaaS model, and outpatient market strength marks a pivotal step in advancing that strategy.